Publications by authors named "Roujun Peng"

Claim this Profile
U
Uncovering the molecular mechanisms of Qingdu Zengye Decoction in the treatment of nasopharyngeal carcinoma: an integrative investigation.
Qi Quan, Zeyu Liu, Ran Ding, Yongmiao Lin, Sihe Zhang, Roujun Peng

Front Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian population.
Qian Cui, Wen Tan, Bao Song, Rou-Jun Peng, Ling Wang

Leukemia· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma.
Yang Liu, Shuang-Yan Ye, Shuai He, Dong-Mei Chi, Xiu-Zhi Wang, Rou-Jun Peng

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.
Da-Feng Lin, Hai-Lin Li, Ting Liu, Xiao-Fei Lv, Chuan-Miao Xie, Rou-Jun Peng

J Natl Cancer Inst· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.
Ying Chen, Wen-Xia Li, Jia-Hua Wu, Geng-Hang Chen, Chun-Min Yang, Rou-Jun Peng

Breast Cancer (Dove Med Press)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioinformatics analysis of MMP14+ myeloid cells affecting endothelial-mesenchymal transformation and immune microenvironment in glioma.
Wei Luo, Qi Quan, Zihao Xu, Jinju Lei, Roujun Peng

Heliyon· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and classification of first primary cancer patients with second primary cancer: a population-based cohort study.
Zhaohui Ruan, Yuetong Zhang, Zhaozhi Li, Jiaxin Jiang, Wei Luo, Roujun Peng

Clin Exp Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma.
Yi-Qi Li, Chun-Ling Luo, Jia-Xin Jiang, Shuai He, Yang Liu, Rou-Jun Peng

Adv Sci (Weinh)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Staging System and Prognostic Model for Malignant Phyllodes Tumor Patients without Distant Metastasis: A Development and Validation Study.
Zhaohui Ruan, Qi Quan, Qianyu Wang, Jiaxin Jiang, Roujun Peng

J Clin Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immune and epithelial-mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas.
Wei Luo, Qi Quan, Jiaxin Jiang, Roujun Peng

Front Genet· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity.
Zhaohui Ruan, Yuetong Zhang, Qi Quan, Jiaxin Jiang, Qianyu Wang, Roujun Peng

Front Genet· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a prognostic model and gene co-expression networks for breast carcinoma based on scRNA-seq and bulk-seq data.
Zhaohui Ruan, Dongmei Chi, Qianyu Wang, Jiaxin Jiang, Qi Quan, Roujun Peng

Ann Transl Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Fulvestrant 500 mg as Maintenance Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Patients with Advanced Breast Cancer After First-Line Chemotherapy.
Fei Xu, Qiufan Zheng, Wen Xia, Quchang Ouyang, Danmei Pang, Roujun Peng

Oncologist· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.
Jing Quan Lim, Dachuan Huang, Tiffany Tang, Daryl Tan, Yurike Laurensia, Rou-Jun Peng

Leukemia· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution.
Yang Liu, Shuai He, Xi-Liang Wang, Wan Peng, Qiu-Yan Chen, Rou-Jun Peng

Nat Commun· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
Xi Wang, Shu-Sen Wang, Heng Huang, Li Cai, Li Zhao, Rou-Jun Peng

JAMA· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.
Jing Quan Lim, Dachuan Huang, Tiffany Tang, Daryl Tan, Yurike Laurensia, Rou-Jun Peng

Leukemia· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Long-Term Zoledronic Acid in Advanced Breast Cancer with Bone Metastasis in South China.
Qianyu Wang, Guifang Guo, Zhaohui Ruan, Huijiao Cao, Ying Guo, Roujun Peng

J Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective study.
Shousheng Liu, Chang Jiang, Lin Yang, Jinsheng Huang, Roujun Peng

Sci Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.
Guo-Wang Lin, Caigang Xu, Kexin Chen, Hui-Qiang Huang, Jieping Chen, Rou-Jun Peng

Lancet Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies.
Miao Xu, Wei-Long Zhang, Qing Zhu, Shanshan Zhang, You-Yuan Yao, Rou-Jun Peng

Theranostics· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.
Yanhong Su, Jiajia Huang, Shusen Wang, Joseph M Unger, Jonathan Arias-Fuenzalida, Roujun Peng

J Natl Cancer Inst· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma.
Miao Xu, Youyuan Yao, Hui Chen, Shanshan Zhang, Su-Mei Cao, Roujun Peng

Nat Genet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma.
Rou-Jun Peng, Bo-Wei Han, Qing-Qing Cai, Xiao-Yu Zuo, Tao Xia

Leukemia· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HK2, PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancer.
Haohua Wang, Roujun Peng, Xiuxing Chen, Rui Jia, Chunyue Huang

Oncol Lett· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis